These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 12727928)
1. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. Martinez NR; Augstein P; Moustakas AK; Papadopoulos GK; Gregori S; Adorini L; Jackson DC; Harrison LC J Clin Invest; 2003 May; 111(9):1365-71. PubMed ID: 12727928 [TBL] [Abstract][Full Text] [Related]
2. (Pro)insulin-specific regulatory T cells. Harrison LC; Solly NR; Martinez NR Novartis Found Symp; 2003; 252():132-41; discussion 141-5, 203-10. PubMed ID: 14609216 [TBL] [Abstract][Full Text] [Related]
3. Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes. Every AL; Kramer DR; Mannering SI; Lew AM; Harrison LC J Immunol; 2006 Apr; 176(8):4608-15. PubMed ID: 16585551 [TBL] [Abstract][Full Text] [Related]
4. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nakayama M; Abiru N; Moriyama H; Babaya N; Liu E; Miao D; Yu L; Wegmann DR; Hutton JC; Elliott JF; Eisenbarth GS Nature; 2005 May; 435(7039):220-3. PubMed ID: 15889095 [TBL] [Abstract][Full Text] [Related]
5. HLA class I epitope discovery in type 1 diabetes. van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554 [TBL] [Abstract][Full Text] [Related]
6. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity. Quinn A; McInerney MF; Sercarz EE J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400 [TBL] [Abstract][Full Text] [Related]
8. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process. Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111 [TBL] [Abstract][Full Text] [Related]
9. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes. Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280 [TBL] [Abstract][Full Text] [Related]
10. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. Santamaria P; Utsugi T; Park BJ; Averill N; Kawazu S; Yoon JW J Immunol; 1995 Mar; 154(5):2494-503. PubMed ID: 7868915 [TBL] [Abstract][Full Text] [Related]
11. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447 [TBL] [Abstract][Full Text] [Related]
12. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242 [TBL] [Abstract][Full Text] [Related]
13. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes. Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498 [TBL] [Abstract][Full Text] [Related]
15. Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin. Griffin AC; Zhao W; Wegmann KW; Hickley WF Am J Pathol; 1995 Sep; 147(3):845-57. PubMed ID: 7545875 [TBL] [Abstract][Full Text] [Related]
16. Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes. Vadacca M; Valorani MG; von Hofe E; Kallinteris NL; Buzzetti R; Pozzilli P Horm Metab Res; 2011 Jun; 43(7):483-8. PubMed ID: 21512962 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice. Mora C; Wong FS; Chang CH; Flavell RA J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997 [TBL] [Abstract][Full Text] [Related]
18. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes. Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801 [TBL] [Abstract][Full Text] [Related]
19. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704 [TBL] [Abstract][Full Text] [Related]
20. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice. Harrison LC; Honeyman MC; Trembleau S; Gregori S; Gallazzi F; Augstein P; Brusic V; Hammer J; Adorini L J Exp Med; 1997 Mar; 185(6):1013-21. PubMed ID: 9091575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]